Export 9 results:
Filters: Author is Norton, Peter J [Clear All Filters]
“An analysis of differential improvement by diagnosis in group transdiagnostic cognitive behaviour therapy for anxiety disorders.”, J Ment Health, vol. 32, no. 3, pp. 619-624, 2023.
“Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.”, Can J Psychiatry, p. 7067437231187459, 2023.
“Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data.”, Psychol Med, pp. 1-13, 2023.
“An examination of sudden gain prevalence across cognitive-behavioural therapy for anxiety and depressive disorders: A quantitative analysis and meta-analytic review.”, J Anxiety Disord, vol. 95, p. 102697, 2023.
“Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework.”, BMC Health Serv Res, vol. 23, no. 1, p. 596, 2023.
“French adaptation and validation of the Panic Disorder Severity Scale-self-report.”, BMC Psychiatry, vol. 22, no. 1, p. 434, 2022.
“Which, who and when? Therapeutic processes in group cognitive behaviour therapy for anxiety disorders.”, Clin Psychol Psychother, vol. 29, no. 5, pp. 1742-1754, 2022.
“Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial.”, Psychol Med, pp. 1-11, 2020.,
“A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.”, BMC Psychiatry, vol. 18, no. 1, p. 320, 2018.,